HIGHLIGHTS
- who: Adam L., Bailey ID and Neil, Anderson from the Department of Pathology and Immunology, Washington University School of Medicine, StLouis, MO, United have published the article: Risks of requiring dedicated molecular strategy for mitigation, in the Journal: PLOS ONE of December/28,/2019
- what: The authors propose utilizing quantitative fourth-generation assay results (S/CO) ratios as a predictor of infection true positivity in situations where the screening assay is reactive but the supplemental test is negative and confirmatory molecular results are not immediately available. The authors show here that requiring a dedicated specimen . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.